. /.   WORLD TRADE  
ORGANIZATION  G/TBT/N/EEC/190 
7 April 2008 
 (08-1541) 
Committee on Technical Barriers to Trade Original:   English 
  
NOTIFICATION 
 
The following notification is being circ ulated in accordance with Article 10.6. 
 
1. Member to Agreement notifying:   EUROPEAN COMMUNITIES
 
If applicable, name of local government involved (Articles 3.2 and 7.2):         
2. Agency responsible:   European Commission 
Name and address (including telephone and fax numbers, e-mail and web-site 
addresses, if available) of  agency or authority designated to handle comments 
regarding the notification shall be  indicated if different from above:    
European Commission 
EC-TBT Enquiry Point 
Fax:  +(32) 2 299 80 43 E-mail:  ec-tbt@ec.europa.eu
 
Website: http://ec.europa.eu/enterprise/tbt/  
3. Notified under Article 2.9.2 [  X ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:         
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading. 
ICS numbers may be provided in  addition, where applicable):   
Cyclohexylhydroxydiazene 1-oxide, potassi um salt (K-HDO); thiabendazole; 
thiamethoxam; IPBC 
5. Title, number of pages and language(s) of the notified document:   Draft Commission 
Directive amending Directive 98/8/EC of the European Parliament and of the Council to 
include cyclohexylhydroxydiazene 1-oxide, pot assium salt (K-HDO) as an active substance 
in Annex I thereto (5 pages, in English). 
 
Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include thiabendazole as an active substance in Anne x I thereto (5 pages, 
in English) 
 Draft Commission Directive amending Directive 98/8/EC of the European Parliament and of the Council to include thiamethoxam as an ac tive substance in Annex I thereto (5 pages, 
in English)  
Draft Commission Directive amending Directive 98/8/EC of the European Parliament and 
of the Council to include IPBC as an active s ubstance in Annex I thereto (5 pages, in 
English) 
6. Description of content:   These four draft Commission Directives include K-HDO, 
thiabendazole, thiamethoxam and IPBC in the European Community positive list of active 
substances, which may be used in biocidal products. G/TBT/N/EEC/190 
Page 2  
 
  7. Objective and rationale, including the na ture of urgent problems where applicable:  
Protection of public health and of the envir onment. Harmonisation of the EU market on 
biocidal products. 
8. Relevant documents:   Directive 98/8/EC of the European Parliament and the Council on 
the placing of biocidal products on the market (OJ L 123, 24.4.1998, page 1). Available in 
all EU languages. 
9. Proposed date of adoption:   
Proposed date of entry into force:    30 June 2008 
31 July 2008 
10. Final date for comments:   60 days from date of notification 
11. Texts available from:  National enquiry point [    ] or address, telephone and fax 
numbers, e-mail and web-site addresses, if available of the other body:   
 European Commission 
EC-TBT Enquiry Point Fax: +(32) 2 299 80 43 Email:  ec-tbt@ec.europa.eu
 
The text is available on the EC-TBT Website: http://ec.europa.eu/enterprise/tbt/  
and 
http://members.wto.org/crnattach ments/2008/tbt/EEC/08_1023_00_e.pdf  
http://members.wto.org/crnattach ments/2008/tbt/EEC/08_1023_01_e.pdf  
http://members.wto.org/crnattach ments/2008/tbt/EEC/08_1023_02_e.pdf  
http://members.wto.org/crnattach ments/2008/tbt/EEC/08_1023_03_e.pdf